Literature DB >> 25319057

Proniosomal oral tablets for controlled delivery and enhanced pharmacokinetic properties of acemetacin.

Tamer M Shehata1, Marwa H Abdallah, Mahmoud Mokhtar Ibrahim.   

Abstract

Free-flowing proniosomal powders of acemetacin (AC) were prepared using the slurry method and maltodextrin as carrier. Positively charged proniosomes composed of 70:20:10 of Span 60/cholesterol (Chol)/stearylamine (SA), respectively, were successively compressed into tablets using direct compression method. The tablets were characterized for weight variability, friability, hardness, drug content uniformity, and dissolution properties. The in vivo evaluation of the prepared proniosomes (powder or tablet forms) after oral administration was investigated by the determination of AC and its active metabolite indomethacin (IND) in the blood of albino rabbits. Results indicated that the increase of Chol from 10% to 20% markedly reduced the efflux of the drug. Further Chol addition from 30% to 50% led to increased AC release rates. The proniosome tablets of AC showed greater hardness and disintegration time and less friability than AC plain tablets. The dissolution of proniosomal tablets indicated a lower drug release percentage compared to powdered proniosomes and AC plain tablets. The mean pharmacokinetic parameters of AC and IND from different formulations indicated increased t 1/2 and area under the curve (AUC) of both AC and IND for proniosomal tablets compared with both proniosomal powders and AC plain tablets. This study suggested the formulation of AC proniosomal powder into tablets to control and extend its pharmacologic effects.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25319057      PMCID: PMC4370976          DOI: 10.1208/s12249-014-0233-5

Source DB:  PubMed          Journal:  AAPS PharmSciTech        ISSN: 1530-9932            Impact factor:   3.246


  11 in total

1.  Proniosomes: a novel drug carrier preparation.

Authors:  C Hu; D G Rhodes
Journal:  Int J Pharm       Date:  1999-08-05       Impact factor: 5.875

2.  SEM imaging predicts quality of niosomes from maltodextrin-based proniosomes.

Authors:  A I Blazek-Welsh; D G Rhodes
Journal:  Pharm Res       Date:  2001-05       Impact factor: 4.200

3.  Preparation and evaluation of reverse-phase evaporation and multilamellar niosomes as ophthalmic carriers of acetazolamide.

Authors:  Ahmed S Guinedi; Nahed D Mortada; Samar Mansour; Rania M Hathout
Journal:  Int J Pharm       Date:  2005-11-02       Impact factor: 5.875

Review 4.  Proniosomes as drug carriers.

Authors:  V Sankar; K Ruckmani; S Durga; S Jailani
Journal:  Pak J Pharm Sci       Date:  2010-01       Impact factor: 0.684

Review 5.  Biophysical aspects of using liposomes as delivery vehicles.

Authors:  Anne S Ulrich
Journal:  Biosci Rep       Date:  2002-04       Impact factor: 3.840

6.  Increasing bioavailability of silymarin using a buccal liposomal delivery system: preparation and experimental design investigation.

Authors:  M S El-Samaligy; N N Afifi; E A Mahmoud
Journal:  Int J Pharm       Date:  2005-12-13       Impact factor: 5.875

7.  Effect of some formulation parameters on flurbiprofen encapsulation and release rates of niosomes prepared from proniosomes.

Authors:  Mahmoud Mokhtar; Omaima A Sammour; Mohammed A Hammad; Nagia A Megrab
Journal:  Int J Pharm       Date:  2008-06-03       Impact factor: 5.875

8.  Pharmacokinetics of acemetacin and its active metabolite indomethacin in rats during acute hepatic damage and liver regeneration.

Authors:  Aracely E Chávez-Piña; Liliana Favari; Gilberto Castañeda-Hernández
Journal:  Ann Hepatol       Date:  2009 Apr-Jun       Impact factor: 2.400

9.  Liposomal diltiazem HCl as ocular drug delivery system for glaucoma.

Authors:  Mahmoud Mokhtar Ibrahim; Salma A H Tawfique; Mahmoud M Mahdy
Journal:  Drug Dev Ind Pharm       Date:  2013-04-09       Impact factor: 3.225

Review 10.  Nanocarriers as pulmonary drug delivery systems to treat and to diagnose respiratory and non respiratory diseases.

Authors:  Malgorzata Smola; Thierry Vandamme; Adam Sokolowski
Journal:  Int J Nanomedicine       Date:  2008
View more
  7 in total

1.  Proniosome: A Promising Approach for Vesicular Drug Delivery.

Authors:  Marzina Ajrin; Fahmida Anjum
Journal:  Turk J Pharm Sci       Date:  2022-08-31

2.  Development, In-Vitro Characterization and Preclinical Evaluation of Esomeprazole-Encapsulated Proniosomal Formulation for the Enhancement of Anti-Ulcer Activity.

Authors:  Dibyalochan Mohanty; Ameeduzzafar Zafar; Mohammed Jafar; Atul Kumar Upadhyay; Mohammad Akiful Haque; Jeetendra Kumar Gupta; Vasudha Bakshi; Mohammed M Ghoneim; Sultan Alshehri; Mohammed Asadullah Jahangir; Mohammed Javed Ansari
Journal:  Molecules       Date:  2022-04-25       Impact factor: 4.927

3.  Development of Provesicular Nanodelivery System of Curcumin as a Safe and Effective Antiviral Agent: Statistical Optimization, In Vitro Characterization, and Antiviral Effectiveness.

Authors:  Farid A Badria; Abdelaziz E Abdelaziz; Amira H Hassan; Abdullah A Elgazar; Eman A Mazyed
Journal:  Molecules       Date:  2020-12-01       Impact factor: 4.411

4.  Proniosomal Telmisartan Tablets: Formulation, in vitro Evaluation and in vivo Comparative Pharmacokinetic Study in Rabbits.

Authors:  Mahmoud Hasan Teaima; Mohamed Yasser; Mohamed Ahmed El-Nabarawi; Doaa Ahmed Helal
Journal:  Drug Des Devel Ther       Date:  2020-03-31       Impact factor: 4.162

Review 5.  Advances of Non-Ionic Surfactant Vesicles (Niosomes) and Their Application in Drug Delivery.

Authors:  Xuemei Ge; Minyan Wei; Suna He; Wei-En Yuan
Journal:  Pharmaceutics       Date:  2019-01-29       Impact factor: 6.321

Review 6.  Lipid-Based Nanovesicular Drug Delivery Systems.

Authors:  Tania Limongi; Francesca Susa; Monica Marini; Marco Allione; Bruno Torre; Roberto Pisano; Enzo di Fabrizio
Journal:  Nanomaterials (Basel)       Date:  2021-12-14       Impact factor: 5.076

Review 7.  Proniosomes derived niosomes: recent advancements in drug delivery and targeting.

Authors:  Maryam Khatoon; Kifayat Ullah Shah; Fakhar Ud Din; Shefaat Ullah Shah; Asim Ur Rehman; Naz Dilawar; Ahmad Nawaz Khan
Journal:  Drug Deliv       Date:  2017       Impact factor: 6.419

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.